Musket David B 4
4 · CAPRICOR THERAPEUTICS, INC. · Filed Apr 24, 2024
Insider Transaction Report
Form 4
Musket David B
Director
Transactions
- Exercise/Conversion
Common Stock
2024-04-23$1.39/sh+16,156$22,457→ 47,692 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-04-23−2,750→ 0 totalExercise: $1.39Exp: 2028-01-02→ Common Stock (2,750 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-04-23−856→ 0 totalExercise: $1.39Exp: 2027-01-03→ Common Stock (856 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-04-23−2,750→ 0 totalExercise: $1.39Exp: 2027-01-03→ Common Stock (2,750 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-04-23−1,050→ 0 totalExercise: $1.39Exp: 2028-01-02→ Common Stock (1,050 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-04-23−3,000→ 0 totalExercise: $1.39From: 2019-08-08Exp: 2029-08-08→ Common Stock (3,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-04-23−5,750→ 0 totalExercise: $1.39Exp: 2029-08-08→ Common Stock (5,750 underlying)
Holdings
- 7,096(indirect: By IRA)
Common Stock
Footnotes (10)
- [F1]This option was granted on January 3, 2017 and was previously reported as covering 8,560 shares at an exercise price of $2.55 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
- [F10]The shares vested 1/48th of the first day of each month, commencing September 1, 2019.
- [F2]The shares vested 1/48th of the first day of each month, commencing February 1, 2017.
- [F3]This option was granted on January 3, 2017 and was previously reported as covering 27,500 shares at an exercise price of $2.55 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
- [F4]The shares vested 1/12th of the first day of each month, commencing February 1, 2017 with the last 1/12th vesting on December 31, 2017.
- [F5]This option was granted on January 2, 2018 and was previously reported as covering 10,500 shares at an exercise price of $1.57 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
- [F6]The shares vested 1/48th of the first day of each month, commencing February 1, 2018.
- [F7]This option was granted on January 2, 2018 and was previously reported as covering 27,500 shares at an exercise price of $1.57 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
- [F8]The shares vested 1/12th of the first day of each month, commencing February 1, 2018 with the last 1/12th vesting on December 31, 2018.
- [F9]This option was granted on August 8, 2019 and was previously reported with an exercise price of $3.25 per share, but was adjusted to reflect a share reprice to $1.39 per share that occurred on February 12, 2020.